ARGONAUT TECHNOLOGIES, INC. AMENDED AND RESTATED CHANGE OF CONTROL SEVERANCE AGREEMENTChange of Control Severance Agreement • April 21st, 2005 • Argonaut Technologies Inc • In vitro & in vivo diagnostic substances • California
Contract Type FiledApril 21st, 2005 Company Industry JurisdictionThis Amended and Restated Change of Control Severance Agreement (the “Agreement”) is made and entered into effective as of August 3, 2004 (the “Effective Date”), by and between Jeff Labadie (the “Employee”) and Argonaut Technologies, Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Section 1 below.
ARGONAUT TECHNOLOGIES, INC. AMENDED AND RESTATED CHANGE OF CONTROL SEVERANCE AGREEMENTChange of Control Severance Agreement • April 21st, 2005 • Argonaut Technologies Inc • In vitro & in vivo diagnostic substances • California
Contract Type FiledApril 21st, 2005 Company Industry JurisdictionThis Amended and Restated Change of Control Severance Agreement (the “Agreement”) is made and entered into effective as of August 3, 2004 (the “Effective Date”), by and between David Foster (the “Employee”) and Argonaut Technologies, Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Section 1 below.
ARGONAUT TECHNOLOGIES, INC. AMENDED AND RESTATED CHANGE OF CONTROL SEVERANCE AGREEMENTChange of Control Severance Agreement • April 21st, 2005 • Argonaut Technologies Inc • In vitro & in vivo diagnostic substances • California
Contract Type FiledApril 21st, 2005 Company Industry JurisdictionThis Amended and Restated Change of Control Severance Agreement (the “Agreement”) is made and entered into effective as of August 3, 2004 (the “Effective Date”), by and between Gordon Tredger (the “Employee”) and Argonaut Technologies, Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Section 1 below.
ARGONAUT TECHNOLOGIES, INC. CHIEF EXECUTIVE OFFICER AMENDED AND RESTATED CHANGE OF CONTROL SEVERANCE AGREEMENTChange of Control Severance Agreement • April 21st, 2005 • Argonaut Technologies Inc • In vitro & in vivo diagnostic substances • California
Contract Type FiledApril 21st, 2005 Company Industry JurisdictionThis Amended and Restated Change of Control Severance Agreement (the “Agreement”) is made and entered into effective as of August 3, 2004 (the “Effective Date”), by and between Lissa Goldenstein (the “Employee”) and Argonaut Technologies, Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Section 1 below.
ARGONAUT TECHNOLOGIES, INC. CHANGE OF CONTROL SEVERANCE AGREEMENTChange of Control Severance Agreement • April 21st, 2005 • Argonaut Technologies Inc • In vitro & in vivo diagnostic substances • California
Contract Type FiledApril 21st, 2005 Company Industry JurisdictionThis Change of Control Severance Agreement (the “Agreement”) is made and entered into effective as of September 01, 2004 (the “Effective Date”), by and between Steve Nelson (the “Employee”) and Argonaut Technologies, Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Section 1 below.